The purpose of the study was to analyze the data of the domestic and foreign specialized literature, which are devoted to the pathogenesis, features of the topography, risk factors, prognosis of the course of bilateral synchronous and metachronous breast cancer. Materials and methods. Analytical and bibliosemantic methods were used in the research. The search for scientific information on bilateral synchronous and metachronous breast cancer for the period from 1990 to 2021 was conducted in databases of electronic searching systems. Results and discussion. Bilateral cancer can be either primary or metastatic to the contralateral breast. Primary one, depending on the time of tumor development in the contralateral breast gland, is divided into synchronous (development interval up to 6 months) and metachronous (development interval more than 6 months). Synchronous tumors of the breast glands are found significantly less frequently (22.7%) than metachronous tumors (69.6%). Relative risk factors for the occurrence of bilateral metachronous breast cancer are the presence of a BRCA1 and BRCA2 gene mutation, a heavy family history of breast cancer in blood relatives, and a young age of up to 45 years. A higher risk was established in patients with a lobular histological type of carcinoma compared to ductal carcinoma and with the absence of expression of steroid hormone receptors in the tumor. Bilateral synchronous tumors are very often characterized by the same visual manifestations during mammography, and their location in the breast glands is a "mirror image". Metachronous tumors are characterized by a smaller size, with rare involvement of axillary lymph nodes. A peculiarity of the topography of metachronous breast cancer is the presence, mainly in the upper outer quadrants of the breast gland, of a fixed or slow-moving nodule of rounded or star shape with unclear contours. Magnetic resonance mammography of the glands is an effective method of comprehensive diagnosis of breast pathology and is performed when other imaging methods are ineffective (sensitivity 99.2%, specificity 97.9%, accuracy 98.9%). The duration of the recurrence-free period in patients with synchronous tumor was 126.3 months, while in patients with metachronous tumor it was 243.7 months. Conclusion. The problem of bilateral breast cancer remains complex and far from fully understood. There are many controversial issues related to the pathogenesis, risk factors, features of the topography, clinical and morphological manifestations, diagnosis, recurrence-free and overall survival of bilateral breast carcinoma, which is important for determining and evaluating the prognosis, as well as the choice of management tactics for such patients
The purpose of the study was to find out the frequency of manifestation of pathological changes in the mammary glands during screening mammographic examination in a randomized sample of mature and elderly women. Materials and methods. According to the results of the processing of a randomized sample of archival anonymized mammograms of 100 women (50 – mature and 50 – elderly) who underwent a screening or preventive examination, the state of breast condition was assessed according to the BI-RADS scale in accordance with the degree of risk of the presence of mammary gland neoplasms, using the following assessment categories: 0 – incomplete study (additional examination is required); 1 – negative (no neoplasm detected); 2 – benign changes. Results and discussion. It was established that among mature and elderly women undergoing screening or preventive mammographic examinations, in 19% only age changes in the mammary gland were verified. Benign changes in the form of calcifications, calcified vessels, axillary or intramammary lymph nodes without metastatic signs of degeneration, which correspond to category 2 on the BI-RADS scale, were found in one mammary gland or bilaterally in 72% of the examined individuals. 28% of examined mature and elderly women need additional examination to verify the diagnosis. It was established that among mature and elderly women, according to mammography data, categories 1 and 2 on the BI-RADS scale are more often manifested on the right, category 0 – on the left, and the frequency of manifestation of changes corresponding to category 0 on the BI-RADS scale among the elderly increases comparing to mature. Studying the frequency of detection of pathological changes in mammary gland during screening examinations in randomized samples can become a theoretical basis for forecasting the dynamics of mammary gland incidence in women of different age groups, identifying risk groups and developing preventive measures for mammary gland pathology of various genesis and methods of its early diagnosis. Conclusion. Among mature and elderly women undergoing screening or preventive mammographic examinations, only age-related changes were verified in the mammary glands in only 19%, and changes which are verified as benign or require additional examination were detected in 81%. According to the results of mammography, 28% of examined mature and elderly women need additional examination to verify the diagnosis. Among mature and elderly women in a randomized sample, according to mammography data, categories 1 and 2 on the BI-RADS scale are more often manifested on the right, category 0 – on the left. The frequency of manifestation of changes corresponding to category 0 on the BI-RADS scale among the elderly increases compared to the mature
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.